T. Rowe Price Associates
RLYB icon

T. Rowe Price Associates’s Rallybio RLYB Stock Holding History

T. Rowe Price Associates’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,596
Closed -$74K – 2908
2023
Q2 		$74K Buy
+1,596
New +$78.2K ﹤0.01% 2750

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates's RLYB Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Rallybio (RLYB) in Q3 2023, closing a stake of 1,596 shares — an estimated $74K sold.

T. Rowe Price Associates first reported a position in RLYB in Q2 2023 and held it in 1 quarter. The position peaked at $74K in Q2 2023. 58 funds tracked by Wall St. Rank hold RLYB as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Rallybio position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,596 Rallybio shares in Q3 2023, an estimated $74K.
  • T. Rowe Price Associates first reported a position in Rallybio in Q2 2023 and held it in 1 quarter.
  • T. Rowe Price Associates's Rallybio position peaked at $74K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Rallybio as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.